Q1 2024 Revenue Increased 10% to $46.5 Million ENGLEWOOD, Colo., April 30, 2024 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
They finally did it. Click here to view original post
Rocky Mountain Life Sciences Investor & Partnering Conference to Welcome More than 200 Attendees Denver – Colorado BioScience Association (CBSA) will highlight the future of health innovation at the Rocky Mountain Life Sciences Investor and […]
On Friday, August 4, the Colorado Prescription Drug Affordability Board (PDAB) selected five drugs for affordability reviews: Enbrel, Genvoya, Cosentyx, Stelara, and Trikafta. PDAB staff plan to begin conducting affordability reviews for the first three […]
Copyright © 2026 Biotech Networks
